ABSTRACT
We randomized 61 patients with paroxysmal atrial fibrillation (AF) ( < 48 hours from onset) to either sotalol or quinidine treatment. Conversion of rhythm was recorded by Holter monitoring. The starting 80 mg dose of sotalol was repeated at 2, 6, and 10 hours if AF persisted (heart rate > 80 beats/min), and if systolic blood was > or = 120 mm Hg. In the quinidine group, if heart rate > 100 beats/min, it was decreased with intravenous digoxin, whereafter 200 mg of oral quinidine sulfate was given maximally 3 times, each dose 2 hours apart. Conversion of AF to sinus rhythm occurred in 17 or 33 patients (52%) taking sotalol, and in 24 of 28 patients (86%) taking quinidine (p < 0.0001). Electric cardioversion was necessary in 39% of the former and in 14% of the latter group. The mean delay from first trial drug to sinus rhythm with the trial medication was 10.2 +/- 7.6 hours in the sotalol group and 4.0 +/- 2.9 hours in the quinidine group (p < 0.01). Treatment was discontinued in 16 patients taking sotalol (48%) because of asymptomatic bradycardia or hypotension, and in 20 taking quinidine (71%) because of rhythm conversion. Asymptomatic wide complex tachycardia (QRS > 0.12 second) was found in 13% and 27% of patients taking sotalol and quinidine, respectively. The longest RR intervals were 6.4 and 3.8 seconds in the sotalol and quinidine groups, respectively. Oral sotalol did not appear as effective as quinidine sulfate treatment in conversion of paroxysmal AF.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Atrial Fibrillation/drug therapy , Digoxin/administration & dosage , Quinidine/administration & dosage , Sotalol/administration & dosage , Acute Disease , Adult , Aged , Atrial Fibrillation/physiopathology , Digoxin/adverse effects , Drug Therapy, Combination , Female , Heart Rate/drug effects , Humans , Male , Middle Aged , Quinidine/adverse effects , Sotalol/adverse effects , Tachycardia/chemically induced , Time FactorsABSTRACT
Two cases of small-bowel infarction preoperatively diagnosed with 99mTc-HMPAO labelled leucocyte imaging are reported. Uptake in the affected gut was positive in images recorded after only 30 min, which is helpful for early diagnosis and therapeutic strategy.
Subject(s)
Infarction/diagnostic imaging , Jejunum/blood supply , Leukocytes , Organotechnetium Compounds , Oximes , Aged , Aged, 80 and over , Female , Humans , Male , Mesenteric Vascular Occlusion/diagnostic imaging , Middle Aged , Radionuclide Imaging , Technetium Tc 99m Exametazime , Thrombosis/diagnostic imaging , Time FactorsABSTRACT
Forty-five patients with various inflammatory diseases were imaged with 99Tcm-HMPAO labelled leucocytes and 99Tcm-nanocolloid within 7 days. The overall sensitivity of 99Tcm-leucocytes was 97% and that of 99Tcm-nanocolloid 59% and both agents had a 100% specificity. The 99Tcm-leucocyte method showed reliable results in various inflammatory and infectious conditions, and seems suitable as a primary imaging method. On the contrary, 99Tcm-nanocolloid cannot be recommended for use in inflammatory bowel diseases, soft tissue abscesses or prosthetic vascular graft infections. However, 99Tcm-nanocolloid gave reliable information in inflammatory and infectious bone and joint diseases in which it had a 90% sensitivity and 100% specificity. In those lesions the 99Tcm-nanocolloid method may be useful, because it is simple, fast and cheap. Yet, further evaluation is needed.
Subject(s)
Inflammation/diagnostic imaging , Organotechnetium Compounds , Oximes , Technetium Tc 99m Aggregated Albumin , Abscess/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Arthritis/diagnostic imaging , Blood Vessel Prosthesis/adverse effects , Child , Child, Preschool , Female , Humans , Infant , Inflammatory Bowel Diseases/diagnostic imaging , Leukocytes , Male , Middle Aged , Osteitis/diagnostic imaging , Radionuclide Imaging , Sensitivity and Specificity , Technetium Tc 99m ExametazimeABSTRACT
Forty-three patients with suspected benign, inflammatory, or infectious diseases were imaged with [99mTc]HM-PAO-labeled leukocytes and [67Ga]citrate. Technetium-99m leukocytes showed 22 true-positive, no false-positive, 19 true-negative, and two false-negative findings and [67Ga]citrate 23, 7, 12 and 1, respectively. The sensitivity, specificity, and accuracy values with 99mTc leukocytes were 92%, 100%, and 95%, and with [67Ga]citrate 96%, 63%, and 81%. Technetium-99m leukocyte scintigraphy has a promising future in comparison with [67Ga]citrate because of the ready availability of [99mTc]HM-PAO, the good image quality, more rapid results (within few hours), and the lower radiation exposure to the patient with 99mTc leukocytes. The usefulness of 99mTc leukocytes in chronic osteomyelitis needs further evaluation.
Subject(s)
Citrates , Inflammation/diagnostic imaging , Leukocytes , Organometallic Compounds , Oximes , Technetium , Abdomen , Abscess/diagnostic imaging , Adult , Aged , Blood Vessel Prosthesis , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/secondary , Citric Acid , Female , Hip Prosthesis , Humans , Ilium , Infections/diagnostic imaging , Lymphoma/diagnostic imaging , Male , Middle Aged , Radionuclide Imaging , Technetium Tc 99m ExametazimeABSTRACT
20 patients were studied with 99mTcHMPAO labelled leucocytes for detection of inflammation. 14 patients had positive uptake. 6 patients were examined also with 67Ga-citrate and 5 with 99mTc-nanocolloid. The 99mTc-HMPAO images were superior to other methods. Abscesses, osteitis, inflammatory bowel disease and graft infection were positive. Abscesses were positive at 30 min images and became more positive at 4 h. The 99mTc-HMPAO labelled leucocyte scan can be used also to follow up healing of inflammation.
